Impairment of cytokinesis by cancer-associated DAPK3 mutations.

Death-associated protein kinase 3 (DAPK3), a member of the DAPK family, contributes to cytokinesis by phosphorylating myosin II regulatory light chain (MRLC). Missense mutations in DAPK3, T112M, D161N, and P216S, were observed in the lung, colon, and cervical cancers, respectively, but the effects of these mutations on cytokinesis remain unclear. Here, we show that cells expressing EGFP-DAPK3-T112M, -D161N, or -P216S exhibited reduced rates of cytokinesis, with an increased ratio of multinucleated cells. In addition, these cells exhibited reduced levels of phosphorylated MRLC at the contractile ring. Collectively, our data demonstrates that cancer-associated DAPK3 mutations impair cytokinesis by reducing phosphorylated MRLC. Copyright © 2020 Elsevier Inc. All rights reserved.

Citation

Taichiro Ono, Fumi Terada, Misako Okumura, Takahiro Chihara, Kozue Hamao. Impairment of cytokinesis by cancer-associated DAPK3 mutations. Biochemical and biophysical research communications. 2020 Dec 17;533(4):1095-1101

Mesh Tags

Substances

PMID: 33032825

search → result